Here's Why Sallie Mae (SLM) Is a Great 'Buy the Bottom' Stock Now
ZACKS· 2025-06-12 14:56
Shares of Sallie Mae (SLM) have been struggling lately and have lost 5.5% over the past two weeks. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support with bulls being able to counteract the bears. So, it could witness a trend reversal down the road.While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts about the future ear ...
Should You Buy Allegro MicroSystems, Inc. (ALGM) After Golden Cross?
ZACKS· 2025-06-12 14:56
Allegro MicroSystems, Inc. (ALGM) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, ALGM's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross."A golden cross is a technical chart pattern that can signify a potential bullish breakout. It's formed from a crossover involving a security's short-term moving average breaking above a longer-term moving average, with the most common moving av ...
Bears are Losing Control Over P3 Health Partners (PIII), Here's Why It's a 'Buy' Now
ZACKS· 2025-06-12 14:56
The price trend for P3 Health Partners Inc. (PIII) has been bearish lately and the stock has lost 13.1% over the past two weeks. However, the formation of a hammer chart pattern in its last trading session indicates that the stock could witness a trend reversal soon, as bulls might have gained significant control over the price to help it find support.While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wal ...
Wall Street Analysts Believe Upbound Group (UPBD) Could Rally 39.33%: Here's is How to Trade
ZACKS· 2025-06-12 14:56
Shares of Upbound Group (UPBD) have gained 5% over the past four weeks to close the last trading session at $26.29, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $36.63 indicates a potential upside of 39.3%.The mean estimate comprises eight short-term price targets with a standard deviation of $8.07. While the lowest estimate of $26 indicates a 1.1% decline from the current pr ...
Does DigitalBridge (DBRG) Have the Potential to Rally 56.63% as Wall Street Analysts Expect?
ZACKS· 2025-06-12 14:56
Shares of DigitalBridge (DBRG) have gained 11.8% over the past four weeks to close the last trading session at $10.63, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $16.65 indicates a potential upside of 56.6%.The mean estimate comprises 10 short-term price targets with a standard deviation of $2.71. While the lowest estimate of $10.50 indicates a 1.2% decline from the current ...
Wall Street Analysts See a 158.17% Upside in Immunome (IMNM): Can the Stock Really Move This High?
ZACKS· 2025-06-12 14:56
Shares of Immunome, Inc. (IMNM) have gained 19.1% over the past four weeks to close the last trading session at $9.49, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $24.50 indicates a potential upside of 158.2%.The mean estimate comprises eight short-term price targets with a standard deviation of $5.76. While the lowest estimate of $20 indicates an 110.8% increase from the cu ...
Victoria's Secret: I Don't See Any Upside Potential In The Near Term
Seeking Alpha· 2025-06-12 14:51
Group 1 - The stock of Victoria's Secret & Co. (NYSE: VSCO) is currently rated as a hold due to its challenging position in the market [1] - There are early signs indicating that the turnaround of the core intimates business is gaining traction [1] - The investment approach focuses on understanding the core economics of a business, including competitive moat, unit economics, reinvestment runway, and management quality [1] Group 2 - The analysis emphasizes the importance of long-term free cash flow generation and shareholder value creation [1] - The author aims to provide insights that help readers focus on what drives long-term equity value [1] - The analysis is intended to be both analytical and accessible, adding value to readers seeking high-quality, long-term investment opportunities [1]
Home Depot's Margins Hold Steady: Is Top-Line Growth Stalling?
ZACKS· 2025-06-12 14:50
Key Takeaways HD maintained gross margin of 33.8% and operating margin of 13.2% in Q1 fiscal 2025 despite cost pressures. Comps fell 0.3% as customers favored smaller DIY projects over large remodels amid high interest rates. Investments in Pro ecosystem, Magic Apron and exclusive brands aim to drive future top-line growth.Margins are a vital indicator of operational efficiency, and for The Home Depot Inc. (HD) , margins are its core strength. With its scale-driven cost leverage, tight inventory controls ...
Are Retail-Wholesale Stocks Lagging Dollar General (DG) This Year?
ZACKS· 2025-06-12 14:46
For those looking to find strong Retail-Wholesale stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Dollar General (DG) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Retail-Wholesale sector should help us answer this question.Dollar General is one of 209 companies in the Retail-Wholesale group. The Retail-Wholesale group currently sits at #9 within the Zacks Sector Rank. The Zacks ...
Are Medical Stocks Lagging Astellas Pharma (ALPMY) This Year?
ZACKS· 2025-06-12 14:46
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Astellas Pharma Inc. (ALPMY) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.Astellas Pharma Inc. is one of 998 individual stocks in the Medical sector. Collectively, these companies sit at #6 in the Zacks Sec ...